Narcolepsy or Idiopathic Hypersomnia (CRYSTAL-1) - Clinical Research Study

Summary

A study to evaluate how well a the study drug, ORX750, works as a possible treatment for sleep-wake disorders, such as narcolepsy and idiopathic hypersomnia.

Eligibility

Currently recruiting participants: Yes

Eligible ages: 18 to 65

Inclusion criteria:

You may be eligible if:
- you are 18 to 65 years of age
- have been diagnosed with narcolepsy or hypersomnia

Exclusion criteria:

You may not be eligible to participate if:
- you do not have narcolepsy or hypersomnia
- you are under the age of 18
- you are currently pregnant, planning to become pregnant in the near future, or breastfeeding.

Participate

This study is not currently accepting expressions of interest via the website. Please see contact information below.

Additional information

Contact information

Please contact the study doctor, Dr. Marcus Povitz at mpovitz@ucalgary.ca, or the study coordinator, Jill Raneri at jkraneri@ucalgary.ca or by phone at 403-519-6591.

Principal investigator:

Marcus Povitz

Clinical trial:

Yes

REB-ID:

REB25-0530